BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27902468)

  • 1. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
    Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
    Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Application of Cell Penetrating R11 Peptide for Diagnosis of Bladder Cancer.
    Du Y; Wang L; Wang W; Guo T; Zhang M; Zhang P; Zhang Y; Wu K; Li A; Wang X; He J; Fan J
    J Biomed Nanotechnol; 2018 Jan; 14(1):161-167. PubMed ID: 29463373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles.
    Wadajkar AS; Menon JU; Tsai YS; Gore C; Dobin T; Gandee L; Kangasniemi K; Takahashi M; Manandhar B; Ahn JM; Hsieh JT; Nguyen KT
    Biomaterials; 2013 May; 34(14):3618-25. PubMed ID: 23419645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells.
    Wang X; Tu M; Tian B; Yi Y; Wei Z; Wei F
    Anal Biochem; 2016 Nov; 512():8-17. PubMed ID: 27523645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus.
    Zhang T; Wu K; Ding C; Sun K; Guan Z; Wang X; Hsieh JT; He D; Fan J
    Oncotarget; 2015 Nov; 6(35):37782-91. PubMed ID: 26462022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
    Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
    J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
    Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
    Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
    Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
    Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER
    Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanosized delivery system of superparamagnetic iron oxide for tumor MR imaging.
    Lee ES; Lim C; Song HT; Yun JM; Lee KS; Lee BJ; Youn YS; Oh YT; Oh KT
    Int J Pharm; 2012 Dec; 439(1-2):342-8. PubMed ID: 22959991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
    Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
    Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection.
    Xu F; Lei D; Du X; Zhang C; Xie X; Yin D
    Contrast Media Mol Imaging; 2011; 6(1):46-54. PubMed ID: 20865697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
    Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H
    Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
    Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.
    Feng ST; Li H; Luo Y; Cai H; Dong Z; Fang Z; Shuai X; Li ZP
    Curr Cancer Drug Targets; 2016; 16(6):551-60. PubMed ID: 27262319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
    Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
    Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
    Wen M; Li B; Ouyang Y; Luo Y; Li S
    Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
    Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
    Wang S; Yang W; Du H; Guo F; Wang H; Chang J; Gong X; Zhang B
    Nanotechnology; 2016 Apr; 27(16):165101. PubMed ID: 26941226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.